Taipei, China

Chen-Chia Lee

This inventor holds 1 USPTO granted patent. Top assignee: Phytohealth Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chen-Chia Lee. Retrieved from https://idiyas.com/inventor/chen-chia-lee-p0la8plm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chen-Chia Lee: Innovator in Diabetes Treatment

Introduction

Chen-Chia Lee is a notable inventor based in Taipei, CN. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative approach combines traditional herbal ingredients to create effective medical solutions.

Latest Patents

Chen-Chia Lee holds 1 patent for a pharmaceutical composition aimed at treating diabetes. This composition includes Ramulus Cinnamomi, Radix et Rhizoma Rhei, Semen Persicae, and Radix Rhizoma Glycyrrhizae. The invention also outlines the use of this composition for the manufacture of a medicament specifically for treating type II diabetes.

Career Highlights

Chen-Chia Lee is associated with Phytohealth Corporation, where he continues to develop innovative solutions in the pharmaceutical sector. His work focuses on integrating traditional medicine with modern scientific approaches to enhance treatment efficacy.

Collaborations

Some of his notable coworkers include Tsung-Shann Jiang and Wen-Hwa Chen, who contribute to the collaborative efforts in research and development at Phytohealth Corporation.

Conclusion

Chen-Chia Lee's contributions to diabetes treatment through his innovative pharmaceutical compositions highlight the importance of integrating traditional knowledge with modern science. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…